Tomorrow Capital

Tomorrow Capital is a Mumbai-based early-stage operational VC with a clear focus on tech-enabled healthcare delivery and consumer wellness brands, writing checks in the $1M to $5M range across pre-seed, seed, and Series A. The firm’s portfolio includes companies like India IVF and Zeno Health, which signal the partner team’s appetite for full-stack care delivery models and pharmacy-anchored consumer health businesses rather than pure software platforms. Tomorrow describes itself as operationally hands-on, and that posture is central to its identity: the partners expect to engage with portfolio companies on operating cadence, hiring, unit-economic discipline, and category positioning, which is a feature for founders who want a partner with operating reps and a friction point for founders who prefer a hands-off cap table. The geographic focus is India, with deep tier-one and tier-two city operating expertise. The right founder profile is a CEO building a tech-enabled care delivery business, a specialty clinic chain, a pharmacy or diagnostics platform, or a consumer health brand with strong margin discipline and the operational chops to execute on the ground in India. The wrong fit is a B2B SaaS company selling to US hospitals, a deep-tech medical device, or an AI-only platform without a meaningful services or commerce wrapper; Tomorrow is explicit that its AI focus is not the defining lens. The right entry path is through Mumbai healthcare-operator networks, through alumni of consumer-internet companies who have moved into health, and through warm introductions from co-investors at firms like Sequoia, Elevation, and Lightspeed who frequently syndicate with Tomorrow. When pitching, lead with operating metrics: clinic-level P&L, customer cohorts, retention, gross margin, working capital cycle, and the specific reason your operating model is replicable across geographies. Then layer in the technology and brand story. Caveats: Tomorrow’s operationally intensive style means partner bandwidth is concentrated, so the firm runs a focused portfolio rather than a sprawling one, and founders who do not align on operating philosophy may experience friction. Use Tomorrow as the partner who brings genuine operating discipline to a tech-enabled care delivery or consumer health business, and bring in pure-tech investors elsewhere on the cap table for balance.